Celcuity: Funding, Investors & Team (Oct 2026)
Celcuity is a biotech company in the clinical stage that is dedicated to using innovative companion diagnostics and expanding treatment options for cancer patients by identifying new cancer sub-types. Through their advanced diagnostic platform, CELsignia, they analyze living tumor cells to better understand the cellular activity behind a patient's cancer. As a result, Celcuity is able to identify cancer sub-types that are not visible through traditional molecular diagnostics. Their ultimate mission is to enhance patient outcomes and revolutionize how pharmaceutical companies identify the appropriate patient populations for their targeted therapies.
Celcuity has raised $770M across 5 funding rounds on record, the most recent an undisclosed round of $500M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Celcuity Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Celcuity Funding Rounds
Celcuity raised $100M in a Post-IPO Equity announced in May 2022.
7 months later, an undisclosed round of $20.0M was announced in Dec 2022.
10 months later, an undisclosed round of $50.0M was announced in Oct 2023.
7 months later, an undisclosed round of $100M was announced in May 2024.
2.1 years later, an undisclosed round of $500M was announced in Jun 2026.
Celcuity Founders and Leadership Team
Contact details for the Celcuity team: 1 of 2 have an email address on file.
Start 14-day free trial →Celcuity Funding Compared to Other Biotechnology Startups
Celcuity's latest round of $500M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Celcuity in Biotechnology and Hamel
Companies Similar to Celcuity
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Celcuity Funding FAQs
What does Celcuity do?
Celcuity is a biotech company in the clinical stage that is dedicated to using innovative companion diagnostics and expanding treatment options for cancer patients by identifying new cancer sub-types. Through their advanced diagnostic platform, CELsignia, they analyze living tumor cells to better understand the cellular activity behind a patient's cancer. As a result, Celcuity is able to identify cancer sub-types that are not visible through traditional molecular diagnostics. Their ultimate mission is to enhance patient outcomes and revolutionize how pharmaceutical companies identify the appropriate patient populations for their targeted therapies.
How much funding has Celcuity raised?
Celcuity has raised $770M across 5 rounds on record. The most recent is an undisclosed round of $500M announced in Jun 2026.
When did Celcuity last raise funding?
Celcuity's most recent funding round on record is an undisclosed round of $500M, announced in Jun 2026.
Who founded Celcuity?
FundedIQ lists Lance Laing (Founder) at Celcuity.
Who is the CEO of Celcuity?
Brian Sullivan is listed as CEO at Celcuity.
Where is Celcuity headquartered?
Celcuity is based in Hamel, Minnesota, United States.
How many employees does Celcuity have?
Celcuity is in the 11-50 employee band.
How does Celcuity's funding compare to other Biotechnology startups?
Celcuity's latest round of $500M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Celcuity Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Celcuity is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.